Daily Brief Archive: July 8, 2026 — U.S. & Hong Kong Stock Analysis
Free previewU.S. Markets
- Chips sold again: Samsung's print missed the loftiest bar and DeepSeek's own-chip report hit — Nasdaq -1.2%
- S&P -0.45% to 7,503.85, SMH down 3%+ as pricey AI names see profit-taking
- Iran hit a tanker near Hormuz: Brent +3% to $74.16, energy led with XLE +2.8%
- Rivian's 75M-share, $1.5B offering triggered an 18% dilution rout
- Vertex's $10B all-cash Crinetics buyout ($85/share) stokes the biotech M&A wave
Hong Kong
- HK opened soft and closed broadly higher, HS Tech leading; Tencent up seven straight
- Beaten-down internet repairs: Alibaba, Xiaomi and Kuaishou all up 2%+ early
- Domestic-compute narrative builds: Meituan's LongCat-2.0 trained fully on local silicon; Biren +10%
- UBTECH fell another 5.8% as the robotics cool-down continues
- The tanker attack lifted energy; the big-three Chinese oils bounced from oversold
Today's Watchlist
- SK Hynix lists on Nasdaq Jul 10 — memory-trade money faces reallocation
- Tesla earnings Jul 22 and AMD's Advancing AI Jul 23 — two judgment days
- If DeepSeek's own chip is confirmed, the AI-compute narrative gets rewritten
- Hormuz heats up: the fragile US-Iran truce amplifies oil volatility
- SpaceX -6.8% the day after inclusion — the 'inclusion marks the top' pattern strikes again
Deep Dives (0 names)
No deep-dive names match the current filters
Rapid Scan (8 names)
| Ticker | Close | Change | Score | Direction | One-line take |
|---|---|---|---|---|---|
 PTCTUS | $89.2 | +4.40% | 7 | Long | +4.4% through the 52-week high; long +7.1%, a tailwind name in the biotech M&A wave |
 BMOUS | $178.25 | +1.22% | 6 | Long | +1.2% breaking 52-week highs; long +1.2%, RSI 72 warm but trend is king |
 BNSUS | $86.2 | -1.02% | 5 | Long | -1% consolidating at highs; long -1%, one of the Canadian bank trio, hold |
 NETUS | $268.83 | +8.60% | 7 | Long | +8.6% on volume toward 52-week highs; AI edge-compute story, +12% week — a $250 retest is buyable |
 MNSTUS | $96.92 | -0.46% | 6 | Long | Consolidating at 52-week highs; +18% revenue defensive growth — through $99 opens the chart |
 CAHUS | $239.71 | +0.92% | 6 | Long | +0.9% to fresh 52-week highs, +18% month; drug distribution with defense and momentum |
 BEAMUS | $37.92 | +7.36% | 6 | Long | +7.4% gene-editing breakout to 52-week highs on the M&A wave — fits the next-prey profile |
 DUS | $69.83 | +0.82% | 6 | Long | +0.8% at 52-week highs on 2.5x volume; AI power demand plus a 3.9% yield |